Search

Search Constraints

You searched for: Author/Creator Le Lagadec, Ronan

Search Results

1. A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53. (January 2019)

2. Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms. Issue 3 (9th December 2019)

3. Cyclometalated Ruthenium(II) Complex as a Versatile Catalyst for Living/Controlled Radical Polymerization of Hydrophobic and Hydrophilic Monomers. Issue 1 (15th April 2013)